Blue Arbor Technologies raises $10.5 million in a Series A round led by Ottobock to support U.S. clinical studies and product development for RESTORE™ System.
Blue Arbor Technologies has successfully raised $10.5 million in a Series A funding round. The round was led by Ottobock and aims to support the launch of clinical studies in the U.S. and further product development for their RESTORE™ System. This funding will enable the company to advance its innovative clinical initiatives.
Who to call at Blue Arbor Technologies, and when
A new round usually means Blue Arbor Technologies is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Blue Arbor Technologies raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Blue Arbor Technologies, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Blue Arbor Technologies. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Blue Arbor Technologies
Location
Michigan, United States
About
Blue Arbor Technologies, Inc. is focused on developing innovative neuromuscular interfaces and advanced prosthetic control solutions for individuals with limb loss. Their flagship product, the RESTORE™ Neuromuscular Interface System, is designed to enhance intuitive control and restore natural movement to prosthetic users. The company aims to redefine prosthetic technology by creating devices that adapt to human biology rather than forcing users to adapt to them. Their partnership with Ottobock marks a crucial step toward bringing their technology to clinical trials and market readiness.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Blue Arbor Technologies raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
MichiganManufacturingBiotechnologyHealth CareMedical Device